Cost-benefit analysis of riluzole for the treatment of amyotrophic lateral sclerosis

GM Ginsberg, B Lev - Pharmacoeconomics, 1997 - Springer
We conducted a cost-benefit analysis of riluzole therapy in patients with amyotrophic lateral
sclerosis (ALS; motor neuron disease; Lou Gehrig's disease). The survival of patients with …
被引用次数：25 相关文章

Cost-benefit analysis of riluzole for the treatment of amyotrophic lateral sclerosis

GM Ginsberg, B Lev - PharmacoEconomics, 1997 - pubmed.ncbi.nlm.nih.gov
We conducted a cost-benefit analysis of riluzole therapy in patients with amyotrophic lateral
sclerosis (ALS; motor neuron disease; Lou Gehrig's disease). The survival of patients with …

Cost-benefit analysis of riluzole for the treatment of amyotrophic lateral sclerosis.

GM Ginsberg, B Lev - Pharmacoeconomics, 1997 - europepmc.org
We conducted a cost-benefit analysis of riluzole therapy in patients with amyotrophic lateral
sclerosis (ALS; motor neuron disease; Lou Gehrig's disease). The survival of patients with …

[引用][C] COST-BENEFIT ANALYSIS OF RILUZOLE FOR THE TREATMENT OF AMYOTROPHIC LATERALSCLEROSIS

GM GINSBERG, B LEV - PharmacoEconomics, 1997 - Adis International